Table 5.
99mTc-MIBI PS | SGD + MGD (136 patients) | SGD (126 patients) | MGD (10 patients) | EPP (25 patients) | ||||
---|---|---|---|---|---|---|---|---|
(%) | CI 95% | (%) | CI 95% | (%) | CI 95% | (%) | CI 95% | |
Sensibility | 71 | 64–78 | 74 | 67–81 | 35 | 14–56 | 53 | 35–71 |
Specificity | 98 | 97–99 | 98 | 97–99 | 100 | 100–100 | 100 | 100–100 |
PPV | 93 | 88–98 | 93 | 88–98 | 100 | 100–100 | 100 | 100–100 |
NPV | 90 | 87–93 | 91 | 89–94 | 61 | 44–77 | 83 | 75–91 |
LR+ | 35.1 | 17.5–70.2 | 37.3 | 18.6–74.6 | ||||
LR− | 0.30 | 0.2–0.38 | 0.27 | 0.20–0.35 | 0.65 | 0.47–0.90 | 0.47 | 0.32–0.68 |